A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)

NCT01617187 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Asenapine
DRUG: Placebo Asenapine
DRUG: Olanzapine
DRUG: Placebo Olanzapine

Sponsor

Organon and Co